{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:53:06Z","timestamp":1774968786035,"version":"3.50.1"},"reference-count":317,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00059","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T04:23:51Z","timestamp":1549340631000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders"],"prefix":"10.3389","volume":"10","author":[{"given":"Barry W.","family":"Festoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Citron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"B1","first-page":"62","article-title":"Components and defects of the coagulation system","volume":"3","author":"Berg","year":"1992","journal-title":"Nurse Pract Forum"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1055\/s-2001-18864","article-title":"Disseminated intravascular coagulation in trauma patients","volume":"27","author":"Gando","year":"2001","journal-title":"Semi. Thrombosis Hemostasis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/09680519040100020901","article-title":"The nexus between systemic inflammation and disordered coagulation in sepsis","volume":"10","author":"Opal","year":"2004","journal-title":"J. Endotoxin Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0958-1669(96)80112-1","article-title":"Initiation of blood coagulation: the tissue factor\/factor VIIa complex","volume":"7","author":"Kirchhofer","year":"1996","journal-title":"Curr Opin Biotechnol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7692182","DOI":"10.1155\/2018\/7692182","article-title":"Thrombin inhibition reduces the expression of brain inflammation markers upon systemic LPS treatment","volume":"2018","author":"Shavit Stein","year":"2018","journal-title":"Neural Plast"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.96.20.11023","article-title":"How the protease thrombin talks to cells","volume":"96","author":"Coughlin","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1023\/A:1013900130415","article-title":"Thrombin regulation of cell function through protease-activated receptors: implications for therapeutic intervention","volume":"67","author":"Derian","year":"2002","journal-title":"Biochemistry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.lfs.2003.09.010","article-title":"Proteinase-mediated signaling: proteinase-activated receptors (PARs) and much more","volume":"74","author":"Hollenberg","year":"2003","journal-title":"Life Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1126\/science.6306770","article-title":"Thrombin stimulation of guanosine 3\u2032,5\u2032-monophosphate formation in murine neuroblastoma cells (clone N1E-115)","volume":"221","author":"Snider","year":"1983","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1749-6632.1986.tb34593.x","article-title":"Thrombin interactions with central nervous system tissue and implications of these interactions","volume":"485","author":"Means","year":"1986","journal-title":"Ann N Y Acad Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1749-6632.1986.tb34592.x","article-title":"Thrombin effects on cultured nerve cells: clinical implications and evidence for a novel mechanism of neuronal activation","volume":"485","author":"Snider","year":"1986","journal-title":"Ann N Y Acad Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1073\/pnas.85.10.3440","article-title":"Thrombin modulates and reverses neuroblastoma neurite outgrowth","volume":"85","author":"Gurwitz","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S0022-510X(98)00193-2","article-title":"Diagnosis of amyotrophic lateral sclerosis","volume":"160","author":"Rowland","year":"1998","journal-title":"J Neurol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Bruijn","year":"2004","journal-title":"Annu Rev Neurosci."},{"key":"B17","first-page":"24","article-title":"Sclerose des cordons lateraux de la moelle epiniere chez femme hysterique atteinte de contracture permanente des quatre membres","volume":"2","author":"Charcot","year":"1865","journal-title":"Bull Soc Med Hop Paris"},{"key":"B18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","article-title":"Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"16","author":"Writing","year":"2017","journal-title":"Lancet Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/neu.480100503","article-title":"Neurotrophic control of 16S acetylcholinesterase at the vertebrate neuromuscular junction","volume":"10","author":"Fernandez","year":"1979","journal-title":"J Neurobiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1471-4159.1979.tb00387.x","article-title":"Cellular distribution of 16S acetylcholinesterase","volume":"32","author":"Fernandez","year":"1979","journal-title":"J Neurochem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/neu.480110105","article-title":"Bidirectional axonal transport of 16S acetylcholinesterase in rat sciatic nerve","volume":"11","author":"Fernandez","year":"1980","journal-title":"J Neurobiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0306-9877(80)90078-X","article-title":"Neuromuscular junction macromolecules in the pathogenesis of amyotrophic leteral sclerosis","volume":"6","author":"Festoff","year":"1980","journal-title":"Med Hypotheses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mus.880040108","article-title":"Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis","volume":"4","author":"Festoff","year":"1981","journal-title":"Muscle Nerve"},{"key":"B24","first-page":"503","article-title":"Release of acetylcholinesterase in amyotrophic lateral sclerosis","volume":"36","author":"Festoff","year":"1982","journal-title":"Adv Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnmol.2016.00160","article-title":"Neuromuscular junction impairment in amyotrophic lateral sclerosis: reassessing the role of acetylcholinesterase","volume":"9","author":"Campanari","year":"2016","journal-title":"Front Mol Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"E2092","DOI":"10.3390\/ijms18102092","article-title":"Neuromuscular junction dismantling in amyotrophic lateral sclerosis","volume":"18","author":"Cappello","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1083\/jcb.103.4.1415","article-title":"Plasminogen activator in mammalian skeletal muscle: characteristics of effect of denervation on urokinase-like and tissue activator","volume":"103","author":"Festoff","year":"1986","journal-title":"J Cell Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-4684-5302-7_6","article-title":"Proteases, their inhibitors and the extracellular matrix: factors in nerve-muscle development and maintenance","volume":"209","author":"Festoff","year":"1987","journal-title":"Adv Exp Med Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jcp.1041440212","article-title":"Plasminogen activators and their inhibitors in the neuromuscular system: I","volume":"144","author":"Festoff","year":"1990","journal-title":"J Cell Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/jcp.1041440213","article-title":"Plasminogen activators and their inhibitors in the neuromuscular system: II","volume":"144","author":"Festoff","year":"1990","journal-title":"J Cell Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jcp.1041470111","article-title":"Plasminogen activators and inhibitors in the neuromuscular system: III","volume":"147","author":"Festoff","year":"1991","journal-title":"J Cell Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1073\/pnas.87.8.2926","article-title":"Rapid neural regulation of muscle urokinase-like plasminogen activator as defined by nerve crush","volume":"87","author":"Hantai","year":"1990","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1073\/pnas.86.1.362","article-title":"Decrease in plasminogen activator correlates with synapse elimination during neonatal development of mouse skeletal muscle","volume":"86","author":"Hantai","year":"1989","journal-title":"Proc Natl Acad Sci USA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/syn.890200105","article-title":"Synaptic transmission blockade increases plasminogen activator activity in mouse skeletal muscle poisoned with botulinum toxin type A","volume":"20","author":"Tian","year":"1995","journal-title":"Synapse"},{"key":"B35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jnr.490340311","article-title":"Plasminogen activator inhibitor 1, the primary regulator of fibrinolysis, in normal human cerebrospinal fluid","volume":"34","author":"Rao","year":"1993","journal-title":"J Neurosci Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1212\/WNL.42.7.1361","article-title":"Protease nexin I, thrombin- and urokinase-inhibiting serpin, concentrated in normal human cerebrospinal fluid","volume":"42","author":"Festoff","year":"1992","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-8993(92)90958-C","article-title":"Plasminogen activators in the neuromuscular system of the wobbler mutant mouse","volume":"580","author":"Blondet","year":"1992","journal-title":"Brain Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jnr.10000","article-title":"Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle","volume":"66","author":"Magnusson","year":"2001","journal-title":"J Neurosci Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1046\/j.1471-4159.1996.67052188.x","article-title":"Neural thrombin and protease nexin I kinetics after murine peripheral nerve injury","volume":"67","author":"Smirnova","year":"1996","journal-title":"J Neurochem"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jcp.1041590103","article-title":"Activation of serpins and their cognate proteases in muscle after crush injury","volume":"159","author":"Festoff","year":"1994","journal-title":"J Cell Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0197-0186(01)00062-6","article-title":"Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration","volume":"40","author":"Citron","year":"2002","journal-title":"Neurochem Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0074-7696(01)11018-1","article-title":"Plasticity and stabilization of neuromuscular and CNS synapses: interactions between thrombin protease signaling pathways and tissue transglutaminase","volume":"211","author":"Festoff","year":"2001","journal-title":"Int Rev Cytol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0197-0186(00)00044-9","article-title":"Regulation of the dual function tissue transglutaminase\/Galpha(h) during murine neuromuscular development: gene and enzyme isoform expression","volume":"37","author":"Citron","year":"2000","journal-title":"Neurochem Int"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1523\/JNEUROSCI.18-17-06882.1998","article-title":"Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation","volume":"18","author":"Turgeon","year":"1998","journal-title":"J Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S0022-510X(98)00202-0","article-title":"Serpin = serine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis","volume":"160","author":"Chou","year":"1998","journal-title":"J Neurol Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1073\/pnas.92.3.895","article-title":"A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death","volume":"92","author":"Houenou","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"key":"B47","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1055\/s-2007-1001931","article-title":"Extravascular proteolysis and the nervous system: serine protease\/serpin balance","volume":"20","author":"Smirnova","year":"1994","journal-title":"Semi Thrombosis Hemostasis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0753-3322(94)90175-9","article-title":"Serine proteases and their serpin inhibitors in Alzheimer's disease","volume":"48","author":"Ho","year":"1994","journal-title":"Biomed Pharmacother"},{"key":"B49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainres.2011.06.042","article-title":"Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior","volume":"1407","author":"Almonte","year":"2011","journal-title":"Brain Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"E84","DOI":"10.3390\/ijms17010084","article-title":"The importance of thrombin in cerebral injury and disease","volume":"17","author":"Krenzlin","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/neu.480250312","article-title":"Proteolytic activity, synapse elimination, and the Hebb synapse","volume":"25","author":"Liu","year":"1994","journal-title":"J Neurobiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/dbio.1996.0274","article-title":"A molecular mechanism for synapse elimination: novel inhibition of locally generated thrombin delays synapse loss in neonatal mouse muscle","volume":"179","author":"Zoubine","year":"1996","journal-title":"Dev Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF00329440","article-title":"Thrombospondin expression in traumatized skeletal muscle","volume":"261","author":"Watkins","year":"1990","journal-title":"Cell Tissue Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0022-510X(94)90074-4","article-title":"Alterations in serum thrombospondin in patients with amyotrophic lateral sclerosis","volume":"127","author":"Smirnova","year":"1994","journal-title":"J Neurol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0022-510X(92)90271-L","article-title":"Thrombospondin, a platelet alpha-granule and matrix glycoprotein, is increased in muscle basement membrane of patients with amyotrophic lateral sclerosis","volume":"113","author":"Rao","year":"1992","journal-title":"J Neurol Sci"},{"key":"B56","first-page":"286","article-title":"Developmental appearance of thrombospondin in neonatal mouse skeletal muscle","volume":"55","author":"Hantai","year":"1991","journal-title":"Eur J Cell Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0014-5793(94)00663-6","article-title":"Cross-linking of beta-amyloid protein precursor catalyzed by tissue transglutaminase","volume":"349","author":"Ho","year":"1994","journal-title":"FEBS Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e17589","DOI":"10.7554\/eLife.17589","article-title":"Thrombospondin expression in myofibers stabilizes muscle membranes","volume":"5","author":"Vanhoutte","year":"2016","journal-title":"Elife"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3969\/j.issn.1673-5374.2012.22.009","article-title":"Thrombospondins and synaptogenesis","volume":"7","author":"Wang","year":"2012","journal-title":"Neural Regen Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1517\/17460441.2014.941350","article-title":"Designing drugs that encourage spinal cord injury healing","volume":"9","author":"Festoff","year":"2014","journal-title":"Exp Opin Drug Discov."},{"key":"B61","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/0897715041526168","article-title":"Neuroprotective effects of recombinant thrombomodulin in controlled contusion spinal cord injury implicates thrombin signaling","volume":"21","author":"Festoff","year":"2004","journal-title":"J Neurotrauma"},{"key":"B62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jns.2012.08.008","article-title":"Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication","volume":"323","author":"Festoff","year":"2012","journal-title":"J Neurol Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12974-016-0670-z","article-title":"HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease","volume":"13","author":"Festoff","year":"2016","journal-title":"J Neuroinflam"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1549194","DOI":"10.1155\/2017\/1549194","article-title":"Proximate mediators of microvascular dysfunction at the blood-brain barrier: neuroinflammatory pathways to neurodegeneration","volume":"2017","author":"Festoff","year":"2017","journal-title":"BioMed Res Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/364362c0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"364","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"B66","first-page":"338","article-title":"Familial amyotrophic lateral sclerosis","volume":"3","author":"Siddique","year":"1995","journal-title":"Clin Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/archneur.1997.00550220050013","article-title":"Amyotrophic lateral sclerosis","volume":"54","author":"Brown","year":"1997","journal-title":"Arch Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbadis.2014.08.010","article-title":"Sporadic and hereditary amyotrophic lateral sclerosis (ALS)","volume":"1852","author":"Ajroud-Driss","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.2015.122","article-title":"Therapeutic rAAVrh10 mediated SOD1 silencing in adult SOD1(G93A) mice and nonhuman primates","volume":"27","author":"Borel","year":"2016","journal-title":"Hum Gene Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ejmech.2016.02.048","article-title":"Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting","volume":"121","author":"Browne","year":"2016","journal-title":"Eur J Med Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neulet.2016.07.059","article-title":"Silencing strategies for therapy of SOD1-mediated ALS","volume":"636","author":"van Zundert","year":"2017","journal-title":"Neurosci Lett."},{"key":"B72","doi-asserted-by":"publisher","first-page":"023759","DOI":"10.7554\/eLife.23759","article-title":"Nuclear export of misfolded SOD1 mediated by a normally buried NES-like sequence reduces proteotoxicity in the nucleus","volume":"6","author":"Zhong","year":"2017","journal-title":"Elife"},{"key":"B73","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jnnp-2016-313521","article-title":"Defining SOD1 ALS natural history to guide therapeutic clinical trial design","volume":"88","author":"Bali","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrneurol.2012.156","article-title":"Gene expression profiling in human neurodegenerative disease","volume":"8","author":"Cooper-Knock","year":"2012","journal-title":"Nat Rev Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"B76","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"B77","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/brain\/awr365","article-title":"Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72","volume":"135","author":"Cooper-Knock","year":"2012","journal-title":"Brain"},{"key":"B78","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/DNND.S84956","article-title":"The genetics of amyotrophic lateral sclerosis: current insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degen Neurol Neuromusc Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat Genet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.3233\/JAD-2012-129036","article-title":"TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43","volume":"33","author":"Gendron","year":"2013","journal-title":"J Alzheimer's Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"B84","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2007.03.066","article-title":"Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS","volume":"420","author":"Robertson","year":"2007","journal-title":"Neurosci Lett."},{"key":"B85","first-page":"145","article-title":"Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders","volume":"2","author":"Ramanan","year":"2013","journal-title":"Am J Neurodegener Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2014.10.009","article-title":"Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges","volume":"1607","author":"Marangi","year":"2015","journal-title":"Brain Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.neuron.2018.02.027","article-title":"Genome-wide analyses identify KIF5A as a novel ALS gene","volume":"97","author":"Nicolas","year":"2018","journal-title":"Neuron"},{"key":"B88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1192\/bjp.122.1.15","article-title":"Genetic theorizing and schizophrenia","volume":"122","author":"Gottesman","year":"1973","journal-title":"Br J Psychiatry"},{"key":"B89","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-clinpsy-050212-185540","article-title":"Endophenotypes in psychopathology research: where do we stand?","volume":"9","author":"Miller","year":"2013","journal-title":"Annu Rev Clin Psychol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.biopsych.2015.03.021","article-title":"Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis","volume":"77","author":"Rosen","year":"2015","journal-title":"Biol Psychiatry"},{"key":"B91","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuroscience.2009.04.006","article-title":"Endophenotypes in normal brain morphology and Alzheimer's disease: a review","volume":"164","author":"Reitz","year":"2009","journal-title":"Neuroscience"},{"key":"B92","first-page":"225","article-title":"Alzheimer's disease: genetic basis and amyloid imaging as endophenotype","volume":"55","author":"Berti","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"B93","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/0004867411432076","article-title":"Frontotemporal dementia as a frontostriatal disorder: neostriatal morphology as a biomarker and structural basis for an endophenotype","volume":"46","author":"Looi","year":"2012","journal-title":"Aust N Z J Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2047-9158-2-8","article-title":"Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review","volume":"2","author":"Pan","year":"2013","journal-title":"Transl Neurodegener."},{"key":"B95","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00401-014-1251-9","article-title":"The widening spectrum of C9ORF72-related disease; genotype\/phenotype correlations and potential modifiers of clinical phenotype","volume":"127","author":"Cooper-Knock","year":"2014","journal-title":"Acta Neuropathologica"},{"key":"B96","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1590\/1980-57642015DN94000413","article-title":"C9ORF72 and the FTD-ALS spectrum: a systematic review of neuroimaging studies","volume":"9","author":"Prado","year":"2015","journal-title":"Dement Neuropsychol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmedgenet-2016-104271","article-title":"Genetics insight into the amyotrophic lateral sclerosis\/frontotemporal dementia spectrum","volume":"54","author":"Ji","year":"2017","journal-title":"J Med Genet."},{"key":"B98","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1080\/14660820052415925","article-title":"ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers?","author":"Belsh","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"B100","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Motor Neuron Disord."},{"key":"B101","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/brain\/104.2.217","article-title":"Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review","volume":"104","author":"Hudson","year":"1981","journal-title":"Brain"},{"key":"B102","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/WCO.0b013e32834cd50a","article-title":"Guam dementia syndrome revisited in 2011","volume":"24","author":"Lee","year":"2011","journal-title":"Curr Opin Neurol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.pneurobio.2011.04.001","article-title":"The ALS\/PDC syndrome of Guam: potential biomarkers for an enigmatic disorder","volume":"95","author":"McGeer","year":"2011","journal-title":"Progress Neurobiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/17482960802372371","article-title":"The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis","volume":"9","author":"Strong","year":"2008","journal-title":"Amyotrop Lateral Sclerosis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"806306","DOI":"10.1155\/2012\/806306","article-title":"ALS and frontotemporal dysfunction: a review","volume":"2012","author":"Achi","year":"2012","journal-title":"Neurol Res Int."},{"key":"B106","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1515\/aiht-2015-66-2679","article-title":"Molecular basis of ALS and FTD: implications for translational studies","volume":"66","author":"Liscic","year":"2015","journal-title":"Arh Hig Rada Toksikol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI90607","article-title":"Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia","volume":"127","author":"Lall","year":"2017","journal-title":"J Clin Invest."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e83450","DOI":"10.1371\/journal.pone.0083450","article-title":"Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C","volume":"8","author":"Therrien","year":"2013","journal-title":"PLoS ONE"},{"key":"B109","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41588-018-0070-7","article-title":"CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity","volume":"50","author":"Kramer","year":"2018","journal-title":"Nat Genet"},{"key":"B111","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/jamaneurol.2018.0372","article-title":"Selective genetic overlap between amyotrophic lateral sclerosis and diseases of the frontotemporal dementia spectrum","volume":"75","author":"Karch","year":"2018","journal-title":"JAMA Neurol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.brainres.2014.09.041","article-title":"Biomarker development for C9orf72 repeat expansion in ALS","volume":"1607","author":"Mendez","year":"2015","journal-title":"Brain Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13311-016-0503-x","article-title":"Fluid-based biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Vu","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B114","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boillee","year":"2006","journal-title":"Neuron"},{"key":"B115","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J Cell Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00018-013-1480-4","article-title":"Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis","volume":"71","author":"Rizzo","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fncel.2014.00117","article-title":"Microglia centered pathogenesis in ALS: insights in cell interconnectivity","volume":"8","author":"Brites","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neures.2017.09.011","article-title":"The multi-dimensional roles of astrocytes in ALS","volume":"126","author":"Yamanaka","year":"2018","journal-title":"Neurosci Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","article-title":"Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease","volume":"22","author":"Lino","year":"2002","journal-title":"J Neurosci"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat Neurosci"},{"key":"B121","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","article-title":"Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis","volume":"11","author":"Yamanaka","year":"2008","journal-title":"Nat Neurosci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bpa.12352","article-title":"Non-neuronal cells in ALS: Role of glial, immune cells and blood-CNS barriers","volume":"26","author":"Puentes","year":"2016","journal-title":"Brain Pathol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/glia.23003","article-title":"Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis","volume":"64","author":"Qosa","year":"2016","journal-title":"Glia"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1626204","DOI":"10.1155\/2017\/1626204","article-title":"The astrocytic S100B protein with its receptor RAGE is aberrantly expressed in SOD1(G93A) models, and its inhibition decreases the expression of proinflammatory Genes","volume":"2017","author":"Serrano","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B125","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/1073858405278321","article-title":"Reactive astrocytes in neural repair and protection","volume":"11","author":"Sofroniew","year":"2005","journal-title":"Neuroscientist"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/stem.1959","article-title":"Concise review: reactive astrocytes and stem cells in spinal cord injury: good guys or bad guys?","volume":"33","author":"Lukovic","year":"2015","journal-title":"Stem Cells"},{"key":"B127","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B128","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.1523\/JNEUROSCI.2745-14.2015","article-title":"Astrocytes are primed by chronic neurodegeneration to produce exaggerated chemokine and cell infiltration responses to acute stimulation with the cytokines IL-1beta and TNF-alpha","volume":"35","author":"Hennessy","year":"2015","journal-title":"J Neurosci"},{"key":"B129","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2016.04.010","article-title":"Targeting the thrombin receptor modulates inflammation and astrogliosis to improve recovery after spinal cord injury","volume":"93","author":"Radulovic","year":"2016","journal-title":"Neurobiol Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neures.2017.10.004","article-title":"Astrocyte reactivity and astrogliosis after spinal cord injury","volume":"126","author":"Okada","year":"2018","journal-title":"Neurosci Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.2174\/1381612823666170316124500","article-title":"Glial cell: A potential target for cellular and drug based therapy in various CNS diseases","volume":"23","author":"Ahmed","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B132","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X","article-title":"Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis","volume":"49","author":"Almer","year":"2001","journal-title":"Ann Neurol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1046\/j.1471-4159.2001.t01-1-00231.x","article-title":"Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays","volume":"77","author":"Malaspina","year":"2001","journal-title":"J Neurochem."},{"key":"B134","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1046\/j.1471-4159.2002.00968.x","article-title":"Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis","volume":"82","author":"Hensley","year":"2002","journal-title":"J Neurochem"},{"key":"B135","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","article-title":"Inflammatory processes in amyotrophic lateral sclerosis","volume":"26","author":"McGeer","year":"2002","journal-title":"Muscle Nerve"},{"key":"B136","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0022-510X(94)90171-6","article-title":"Evidence for autoimmunity in amyotrophic lateral sclerosis","volume":"124","author":"Appel","year":"1994","journal-title":"J Neurol Sci"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1073\/pnas.91.8.3393","article-title":"Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line","volume":"91","author":"Smith","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B138","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/14660820050515692","article-title":"Immunosuppression and anti-inflammatory agents in ALS","volume":"1","author":"Smith","year":"2000","journal-title":"Amyotroph Later Scler Motor Neuron Disord"},{"key":"B139","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/syn.890200302","article-title":"Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons","volume":"20","author":"Engelhardt","year":"1995","journal-title":"Synapse"},{"key":"B140","first-page":"47","article-title":"Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis","volume":"68","author":"Appel","year":"1995","journal-title":"Adv Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.410350207","article-title":"Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit","volume":"35","author":"Kimura","year":"1994","journal-title":"Ann Neurol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1056\/NEJM198508013130511","article-title":"Isolation of LAV\/HTLV-III from a patient with amyotrophic lateral sclerosis","volume":"313","author":"Hoffman","year":"1985","journal-title":"N Engl J Med."},{"key":"B143","first-page":"131","article-title":"Motor neuron disease and HIV-1 infection in a 30-year-old HIV-positive heroin abuser: a causal relationship?","volume":"17","author":"Galassi","year":"1998","journal-title":"Clin Neuropathol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S1473-3099(01)00108-6","article-title":"HIV may underlie ALS-like condition","volume":"1","author":"Ahmad","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.57.6.1094","article-title":"An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy","volume":"57","author":"MacGowan","year":"2001","journal-title":"Neurology"},{"key":"B146","first-page":"474","article-title":"Reversible ALS-like disorder in HIV infection","volume":"59","author":"von Giesen","year":"2002","journal-title":"Neurology"},{"key":"B147","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.59.3.474","article-title":"Reversible ALS-like disorder in HIV infection","volume":"59","author":"Cone","year":"2002","journal-title":"Neurology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0074-7742(07)82002-2","article-title":"Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune regulatory proteins","volume":"82","author":"Griffiths","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J Clin Invest."},{"key":"B150","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s13311-015-0385-3","article-title":"Neuroinflammation: ways in which the immune system affects the brain","volume":"12","author":"Ransohoff","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B151","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"B152","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.molmed.2017.04.005","article-title":"Should we stop saying \u2018Glia\u2019 and \u2018Neuroinflammation\u2019?","volume":"23","author":"Masgrau","year":"2017","journal-title":"Trends Mol Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fnagi.2017.00242","article-title":"The dual role of microglia in ALS: mechanisms and therapeutic approaches","volume":"9","author":"Geloso","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","article-title":"Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy","volume":"21","author":"Spiller","year":"2018","journal-title":"Nat Neurosci."},{"key":"B155","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci."},{"key":"B156","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.tins.2018.04.002","article-title":"Insights into C9ORF72-Related ALS\/FTD from Drosophila and iPSC Models","volume":"41","author":"Yuva-Aydemir","year":"2018","journal-title":"Trends Neurosci"},{"key":"B157","doi-asserted-by":"publisher","first-page":"E38","DOI":"10.3390\/cells7050038","article-title":"Patient-Derived iPSCs and iNs-shedding new light on the cellular etiology of neurodegenerative diseases","volume":"7","author":"Tang","year":"2018","journal-title":"Cells"},{"key":"B158","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.3390\/brainsci8040050","article-title":"Connexin 43 controls the astrocyte immunoregulatory phenotype","volume":"8","author":"Boulay","year":"2018","journal-title":"Brain Sci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature18928","article-title":"Transfer of mitochondria from astrocytes to neurons after stroke","volume":"535","author":"Hayakawa","year":"2016","journal-title":"Nature"},{"key":"B160","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2016.00107","article-title":"Mitochondria know no boundaries: Mechanisms and functions of intercellular mitochondrial transfer","volume":"4","author":"Torralba","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci."},{"key":"B162","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"B163","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"B164","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B165","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1365-2990.1992.tb00811.x","article-title":"The inflammatory response in the CNS","volume":"18","author":"Perry","year":"1992","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1568010023344698","article-title":"Toll-like receptors and inflammation in the CNS","volume":"1","author":"Lee","year":"2002","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"B168","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.bcp.2011.01.003","article-title":"Evaluating the role of Toll-like receptors in diseases of the central nervous system","volume":"81","author":"Carty","year":"2011","journal-title":"Biochem Pharmacol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/jnr.20767","article-title":"Toll-like receptors in central nervous system glial inflammation and homeostasis","volume":"83","author":"Kielian","year":"2006","journal-title":"J Neurosci Res."},{"key":"B170","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2174\/156652407783220750","article-title":"RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease","volume":"7","author":"Rauvala","year":"2007","journal-title":"Curr Mol Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0404.2008.01133.x","article-title":"Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis","volume":"120","author":"Ilzecka","year":"2009","journal-title":"Acta Neurol Scand."},{"key":"B172","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbi.2014.06.203","article-title":"Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord","volume":"42","author":"Heiman","year":"2014","journal-title":"Brain Behav Immun."},{"key":"B173","doi-asserted-by":"publisher","first-page":"342","DOI":"10.14336\/AD.2015.0521","article-title":"Does infection-induced immune activation contribute to dementia?","volume":"6","author":"Barichello","year":"2015","journal-title":"Aging Dis."},{"key":"B174","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neubiorev.2015.12.006","article-title":"RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis","volume":"62","author":"Ray","year":"2016","journal-title":"Neurosci Biobehav Rev."},{"key":"B175","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0952-79150000191-6","article-title":"Danger signals: SOS to the immune system","volume":"13","author":"Gallucci","year":"2001","journal-title":"Curr Opin Immunol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1586\/eci.12.21","article-title":"The evolution of the danger theory","volume":"8","author":"Matzinger","year":"2012","journal-title":"Exp Rev Clin Immunol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/sj.embor.7400759","article-title":"Alarmin(g) news about danger: workshop on innate danger signals and HMGB1","volume":"7","author":"Harris","year":"2006","journal-title":"EMBO Rep."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu Rev Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12035-012-8264-y","article-title":"HMGB1 in development and diseases of the central nervous system","volume":"45","author":"Fang","year":"2012","journal-title":"Mol Neurobiol"},{"key":"B182","doi-asserted-by":"crossref","first-page":"16722","DOI":"10.1016\/S0021-9258(18)55361-8","article-title":"30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth","volume":"266","author":"Merenmies","year":"1991","journal-title":"J Biol Chem."},{"key":"B183","doi-asserted-by":"crossref","first-page":"19726","DOI":"10.1016\/S0021-9258(19)36575-5","article-title":"Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides","volume":"268","author":"Parkkinen","year":"1993","journal-title":"J Biol Chem."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1161\/ATVBAHA.107.150631","article-title":"Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes","volume":"28","author":"Ito","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"23200","DOI":"10.1074\/jbc.M111.223834","article-title":"High mobility group box-1 (HMGB1; amphoterin) is required for zebrafish brain development","volume":"286","author":"Zhao","year":"2011","journal-title":"J Biol Chem"},{"key":"B186","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/187152711794488601","article-title":"Activation and control of CNS innate immune responses in health and diseases: a balancing act finely tuned by neuroimmune regulators (NIReg)","volume":"10","author":"Hoarau","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"B187","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2006.10.063","article-title":"Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS","volume":"412","author":"Lo Coco","year":"2007","journal-title":"Neurosci Lett"},{"key":"B188","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2011.02.001","article-title":"Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue","volume":"179","author":"Casula","year":"2011","journal-title":"Neuroscience"},{"key":"B189","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fncel.2015.00485","article-title":"Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis","volume":"9","author":"Juranek","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.bcp.2010.01.013","article-title":"Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging","volume":"79","author":"Yan","year":"2010","journal-title":"Biochem Pharmacol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2015.06.011","article-title":"Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease","volume":"72","author":"Schmidt","year":"2015","journal-title":"Vascul Pharmacol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fncel.2016.00117","article-title":"Soluble RAGE treatment delays progression of amyotrophic lateral sclerosis in SOD1 mice","volume":"10","author":"Juranek","year":"2016","journal-title":"Front Cell Neurosci."},{"key":"B193","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4172\/2161-0460.1000421","article-title":"The receptor for advanced glycation endproducts (RAGE) and mediation of inflammatory neurodegeneration","volume":"8","author":"Derk","year":"2018","journal-title":"J Alzheimers Dis Parkinson"},{"key":"B194","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.mad.2010.05.003","article-title":"Mitochondrial dysfunction and intracellular calcium dysregulation in ALS","volume":"131","author":"Kawamata","year":"2010","journal-title":"Mech Ageing Dev."},{"key":"B195","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4103\/1673-5374.200794","article-title":"Current view and perspectives in amyotrophic lateral sclerosis","volume":"12","author":"Mathis","year":"2017","journal-title":"Neural Regen Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol Res."},{"key":"B197","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-94-007-2869-1_12","article-title":"Mitochondria in neurodegeneration","volume":"942","author":"Lezi","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jnc.14037","article-title":"Brain aging and neurodegeneration: from a mitochondrial point of view","volume":"143","author":"Grimm","year":"2017","journal-title":"J Neurochem"},{"key":"B199","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1381612822666161230144517","article-title":"New therapeutics to modulate mitochondrial function in neurodegenerative disorders","volume":"23","author":"Wilkins","year":"2017","journal-title":"Curr Pharm Des."},{"key":"B200","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/(SICI)1098-1136(199912)28:3<215::AID-GLIA5>3.0.CO;2-C","article-title":"Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS)","volume":"28","author":"Levine","year":"1999","journal-title":"Glia"},{"key":"B201","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1089\/ars.2006.8.2075","article-title":"On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis","volume":"8","author":"Hensley","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1471-4159.2008.05699.x","article-title":"Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria","volume":"107","author":"Bilsland","year":"2008","journal-title":"J Neurochem."},{"key":"B203","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1523\/JNEUROSCI.5308-07.2008","article-title":"Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants","volume":"28","author":"Cassina","year":"2008","journal-title":"J Neurosci"},{"key":"B204","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fncel.2015.00203","article-title":"Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling","volume":"9","author":"Rojas","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B205","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.neuron.2016.12.034","article-title":"Transient opening of the mitochondrial permeability transition pore induces microdomain calcium transients in astrocyte processes","volume":"93","author":"Agarwal","year":"2017","journal-title":"Neuron"},{"key":"B206","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nbt.1957","article-title":"Astrocytes from familial and sporadic ALS patients are toxic to motor neurons","volume":"29","author":"Haidet-Phillips","year":"2011","journal-title":"Nat Biotechnol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.stemcr.2017.03.003","article-title":"Sporadic ALS astrocytes induce neuronal degeneration in vivo","volume":"8","author":"Qian","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1126\/science.283.5407.1476","article-title":"Mitochondrial evolution","volume":"283","author":"Gray","year":"1999","journal-title":"Science"},{"key":"B209","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.it.2011.01.005","article-title":"Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation","volume":"32","author":"Krysko","year":"2011","journal-title":"Trends Immunol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3233\/JAD-142334","article-title":"Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells","volume":"45","author":"Wilkins","year":"2015","journal-title":"J Alzheimer's Dis"},{"key":"B211","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mcn.2014.04.003","article-title":"Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia","volume":"60","author":"Little","year":"2014","journal-title":"Mol Cell Neurosci"},{"key":"B212","doi-asserted-by":"publisher","first-page":"E933","DOI":"10.3390\/ijms18050933","article-title":"Fueling inflamm-aging through mitochondrial dysfunction: mechanisms and molecular targets","volume":"18","author":"Picca","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2014.00311","article-title":"Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection","volume":"6","author":"Wilkins","year":"2014","journal-title":"Front Aging Neurosci."},{"key":"B214","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2017.00508","article-title":"Mitochondria-derived damage-associated molecular patterns in neurodegeneration","volume":"8","author":"Wilkins","year":"2017","journal-title":"Front Immunol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneurpsyc.1948.02300410090005","article-title":"Trypan red therapy of amyotrophic lateral sclerosis; preliminary report","volume":"59","author":"Aird","year":"1948","journal-title":"Arch Neurol Psychiatry."},{"key":"B216","first-page":"360","article-title":"The role of tissue permeability with particular reference to the blood-brain barrier in diseases of the central nervous system","volume":"69","author":"Aird","year":"1948","journal-title":"Calif Med."},{"key":"B217","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00005053-196306000-00002","article-title":"The blood-brain barrier in clinical disease: a review","volume":"136","author":"Aird","year":"1963","journal-title":"J Nerv Ment Dis."},{"key":"B218","first-page":"689","article-title":"Muscular atrophies and dystrophies in middle life","volume":"19","author":"Aird","year":"1964","journal-title":"Geriatrics"},{"key":"B219","first-page":"248","article-title":"Significance of the blood-brain barrier in neurological disorders of toxic and metabolic origin","volume":"27","author":"Aird","year":"1964","journal-title":"Rev Neuropsiquiatr."},{"key":"B220","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2007.04.044","article-title":"Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS","volume":"1157","author":"Garbuzova-Davis","year":"2007","journal-title":"Brain Res."},{"key":"B221","doi-asserted-by":"publisher","first-page":"e1205","DOI":"10.1371\/journal.pone.0001205","article-title":"Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS","volume":"2","author":"Garbuzova-Davis","year":"2007","journal-title":"PLoS ONE"},{"key":"B222","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nn2073","article-title":"ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration","volume":"11","author":"Zhong","year":"2008","journal-title":"Nat Neurosci."},{"key":"B223","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2009.09.018","article-title":"Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat","volume":"1301","author":"Nicaise","year":"2009","journal-title":"Brain Res."},{"key":"B224","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1172\/JCI38476","article-title":"Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells","volume":"119","author":"Zhong","year":"2009","journal-title":"J Clin Invest."},{"key":"B225","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3109\/17482960902803457","article-title":"Aquaporin-4 as a potential marker of BBB disruption in ALS models","volume":"11","author":"Nicaise","year":"2010","journal-title":"Amyotrophic Later Sclerosis"},{"key":"B226","doi-asserted-by":"publisher","first-page":"e10614","DOI":"10.1371\/journal.pone.0010614","article-title":"Reduction of circulating endothelial cells in peripheral blood of ALS patients","volume":"5","author":"Garbuzova-Davis","year":"2010","journal-title":"PLoS ONE"},{"key":"B227","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2011.04.049","article-title":"Amyotrophic lateral sclerosis: a neurovascular disease","volume":"1398","author":"Garbuzova-Davis","year":"2011","journal-title":"Brain Res."},{"key":"B228","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2012.05.056","article-title":"Impaired blood-brain\/spinal cord barrier in ALS patients","volume":"1469","author":"Garbuzova-Davis","year":"2012","journal-title":"Brain Res."},{"key":"B229","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-386986-9.00004-1","article-title":"Neurovascular aspects of amyotrophic lateral sclerosis","volume":"102","author":"Rodrigues","year":"2012","journal-title":"Int Rev Neurobiol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","article-title":"Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis","volume":"125","author":"Winkler","year":"2013","journal-title":"Acta Neuropathologica"},{"key":"B231","doi-asserted-by":"publisher","first-page":"E1035","DOI":"10.1073\/pnas.1401595111","article-title":"Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice","volume":"111","author":"Winkler","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B232","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neulet.2010.01.078","article-title":"P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis","volume":"472","author":"Milane","year":"2010","journal-title":"Neurosci Lett."},{"key":"B233","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neulet.2016.12.049","article-title":"Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model","volume":"639","author":"Chan","year":"2017","journal-title":"Neurosci Lett"},{"key":"B234","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fnins.2017.00476","article-title":"Improving the delivery of SOD1 antisense oligonucleotides to motor neurons using calcium phosphate-lipid nanoparticles","volume":"11","author":"Chen","year":"2017","journal-title":"Front Neurosci."},{"key":"B235","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.freeradbiomed.2017.03.034","article-title":"In vivo EPR pharmacokinetic evaluation of the redox status and the blood brain barrier permeability in the SOD1(G93A) ALS rat model","volume":"108","author":"Stamenkovic","year":"2017","journal-title":"Free Radic Biol Med."},{"key":"B236","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2014.05.015","article-title":"Glial cells in amyotrophic lateral sclerosis","volume":"262","author":"Philips","year":"2014","journal-title":"Exp Neurol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1212\/WNL.30.5.453","article-title":"Epidemiology of amyotrophic lateral sclerosis: 1","volume":"30","author":"Kurtzke","year":"1980","journal-title":"Neurology"},{"key":"B238","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archneur.1981.00510040046007","article-title":"Case-control studies of motor neuron disease: association with mechanical injuries","volume":"38","author":"Kondo","year":"1981","journal-title":"Arch Neurol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0022-510X(92)90241-C","article-title":"Mechanical trauma as a risk factor in classic amyotrophic lateral sclerosis: lack of epidemiologic evidence","volume":"113","author":"Kurland","year":"1992","journal-title":"J Neurol Sci."},{"key":"B240","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamaneurol.2015.0910","article-title":"Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study","volume":"72","author":"Kioumourtzoglou","year":"2015","journal-title":"JAMA Neurol"},{"key":"B241","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/aje\/kwv169","article-title":"Physical Trauma and amyotrophic lateral sclerosis: a population-based study using danish National registries","volume":"183","author":"Seals","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/21678421.2017.1386687","article-title":"Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium","volume":"19","author":"Pupillo","year":"2018","journal-title":"Amyotrophic Later Sclerosis Frontotemporal Degener"},{"key":"B243","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain"},{"key":"B244","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/alzrt234","article-title":"Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel","volume":"6","author":"Stein","year":"2014","journal-title":"Alzheimers Res Ther."},{"key":"B245","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jnen\/nlx101","article-title":"Dementia after moderate-severe traumatic brain injury: coexistence of multiple proteinopathies","volume":"77","author":"Kenney","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"e380","DOI":"10.1212\/WNL.0000000000004899","article-title":"Pathologic Thr(175) tau phosphorylation in CTE and CTE with ALS","volume":"90","author":"Moszczynski","year":"2018","journal-title":"Neurology."},{"key":"B247","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12975-011-0125-x","article-title":"Blood-brain barrier pathophysiology in traumatic brain injury","volume":"2","author":"Chodobski","year":"2011","journal-title":"Transl Stroke Res."},{"key":"B248","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jnr.23300","article-title":"Blood-brain barrier and traumatic brain injury","volume":"92","author":"Alves","year":"2014","journal-title":"J Neurosci Res."},{"key":"B249","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s12035-014-8752-3","article-title":"Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury","volume":"51","author":"Abdul-Muneer","year":"2015","journal-title":"Mol Neurobiol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/cphy.c140057","article-title":"Role of microvascular disruption in brain damage from traumatic brain injury","volume":"5","author":"Logsdon","year":"2015","journal-title":"Compr Physiol."},{"key":"B251","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4684-8357-4","article-title":"Scientific Affairs Division, editors","volume-title":"Serine Proteases and Their Serpin Inhibitors in the Nervous System: Regulation in Development and in Degenerative and Malignant Disease","author":"Festoff","year":"1990"},{"key":"B252","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1471-4159.2003.01268.x","article-title":"The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?","volume":"84","author":"Xi","year":"2003","journal-title":"J Neurochem"},{"key":"B253","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","article-title":"Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46","volume":"120","author":"Mosnier","year":"2012","journal-title":"Blood"},{"key":"B254","first-page":"133","article-title":"The role of thrombin and thrombin receptors in the brain","volume-title":"Thrombin: Physiology and Disease.","author":"Luo","year":"2010"},{"key":"B255","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1016\/S0021-9258(18)34276-5","article-title":"Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation","volume":"257","author":"Esmon","year":"","journal-title":"J Biol Chem. ("},{"key":"B256","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1538-7933.2003.00537.x","article-title":"The discovery of thrombomodulin","volume":"2","author":"Esmon","year":"2004","journal-title":"J Thromb Haemost."},{"key":"B257","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1126\/science.1071699","article-title":"Activation of endothelial cell protease activated receptor 1 by the protein C pathway","volume":"296","author":"Riewald","year":"2002","journal-title":"Science"},{"key":"B258","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","article-title":"Thrombomodulin and its role in inflammation","volume":"34","author":"Conway","year":"2012","journal-title":"Semin Immunopathol."},{"key":"B259","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1021\/bi00388a025","article-title":"Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene","volume":"26","author":"Wen","year":"1987","journal-title":"Biochemistry"},{"key":"B260","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0012-1606(87)90312-5","article-title":"Fetomodulin: marker surface protein of fetal development which is modulatable by cyclic AMP","volume":"122","author":"Imada","year":"1987","journal-title":"Dev Biol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0012-1606(90)90058-Q","article-title":"Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays","volume":"140","author":"Imada","year":"1990","journal-title":"Dev Biol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1083\/jcb.101.2.363","article-title":"Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta","volume":"101","author":"Maruyama","year":"1985","journal-title":"J Cell Biol"},{"key":"B263","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood.V67.2.362.362","article-title":"Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain","volume":"67","author":"Ishii","year":"1986","journal-title":"Blood"},{"key":"B264","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(91)90540-C","article-title":"Regional distribution of thrombomodulin in human brain","volume":"556","author":"Wong","year":"1991","journal-title":"Brain Res."},{"key":"B265","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1161\/01.ATV.17.11.3139","article-title":"Thrombomodulin expression in bovine brain capillaries","volume":"17","author":"Wang","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B266","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/(SICI)1098-1136(199703)19:3<259::AID-GLIA8>3.0.CO;2-U","article-title":"Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes","volume":"19","author":"Pindon","year":"1997","journal-title":"Glia"},{"key":"B267","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1523\/JNEUROSCI.20-07-02543.2000","article-title":"Thrombomodulin as a new marker of lesion-induced astrogliosis: involvement of thrombin through the G-protein-coupled protease-activated receptor-1","volume":"20","author":"Pindon","year":"2000","journal-title":"J Neurosci"},{"key":"B268","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuron.2013.12.034","article-title":"Reactive gliosis and the multicellular response to CNS damage and disease","volume":"81","author":"Burda","year":"2014","journal-title":"Neuron"},{"key":"B269","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama","year":"2005","journal-title":"J Clin Invest."},{"key":"B270","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/BRS.0b013e3181bd14b6","article-title":"High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis","volume":"35","author":"Kawabata","year":"2010","journal-title":"Spine"},{"key":"B271","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1182\/blood-2008-03-142760","article-title":"Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"key":"B272","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/01.ta.0000251420.41427.d3","article-title":"Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers","volume":"63","author":"Iba","year":"2007","journal-title":"J Trauma."},{"key":"B273","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/shk.0b013e31804f7844","article-title":"SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia","volume":"28","author":"Ogura","year":"2007","journal-title":"Shock"},{"key":"B274","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1097\/00003246-200009001-00017","article-title":"Phylogenetic and functional relationships between coagulation and the innate immune response","volume":"28","author":"Opal","year":"2000","journal-title":"Crit Care Med."},{"key":"B275","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-017-1808-9","article-title":"Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury","volume":"21","author":"Wada","year":"2017","journal-title":"Critical Care"},{"key":"B276","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease","volume":"8","author":"Grammas","year":"2011","journal-title":"J Neuroinflam"},{"key":"B277","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fnagi.2018.00245","article-title":"Blood-cerebrospinal fluid barrier gradients in mild cognitive impairment and alzheimer's disease: relationship to inflammatory cytokines and chemokines","volume":"10","author":"Ott","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"B278","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neulet.2015.05.028","article-title":"Brain pericytes are the most thrombin-sensitive matrix metalloproteinase-9-releasing cell type constituting the blood-brain barrier in vitro","volume":"599","author":"Machida","year":"2015","journal-title":"Neurosci Lett."},{"key":"B279","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neuroscience.2017.03.026","article-title":"Role of thrombin-PAR1-PKCtheta\/delta axis in brain pericytes in thrombin-induced MMP-9 production and blood-brain barrier dysfunction in vitro","volume":"350","author":"Machida","year":"2017","journal-title":"Neuroscience"},{"key":"B280","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3171\/2010.6.JNS10207","article-title":"The role of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury","volume":"114","author":"Higashida","year":"2011","journal-title":"J Neurosurg."},{"key":"B281","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12031-012-9769-6","article-title":"Potential contribution of hypoxia-inducible factor-1alpha, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage","volume":"48","author":"Wang","year":"2012","journal-title":"J Mol Neurosci."},{"key":"B282","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"B283","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1160\/th14-02-0167","article-title":"Protease-activated receptor signalling by coagulation proteases in endothelial cells","volume":"112","author":"Rezaie","year":"2014","journal-title":"Thromb Haemost."},{"key":"B284","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.vph.2014.06.001","article-title":"Functional role of protease activated receptors in vascular biology","volume":"62","author":"Alberelli","year":"2014","journal-title":"Vascul Pharmacol"},{"key":"B285","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00001721-199510000-00001","article-title":"Vascular endothelial cell activation and permeability responses to thrombin","volume":"6","author":"Garcia","year":"1995","journal-title":"Blood Coagul Fibrinol"},{"key":"B286","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1013904231324","article-title":"Molecular mechanisms of thrombin-induced endothelial cell permeability","volume":"67","author":"Bogatcheva","year":"2002","journal-title":"Biochemistry"},{"key":"B287","doi-asserted-by":"publisher","first-page":"C1234","DOI":"10.1152\/ajpcell.00551.2007","article-title":"Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA\/Rho kinase-myosin phosphatase axis","volume":"294","author":"van Nieuw Amerongen","year":"2008","journal-title":"Am J Physiol Cell Physiol."},{"key":"B288","first-page":"1677","article-title":"Effect of thrombin on blood brain barrier permeability and its mechanism","volume":"117","author":"Guan","year":"2004","journal-title":"Chin Med J"},{"key":"B289","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1523\/JNEUROSCI.18-04-01393.1998","article-title":"Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes","volume":"18","author":"Taoka","year":"1998","journal-title":"J Neurosci"},{"key":"B290","doi-asserted-by":"publisher","first-page":"e0170512","DOI":"10.1371\/journal.pone.0170512","article-title":"Protease-Activated Receptor-1 supports locomotor recovery by biased agonist activated protein c after contusive spinal cord injury","volume":"12","author":"Whetstone","year":"2017","journal-title":"PLoS ONE"},{"key":"B291","doi-asserted-by":"publisher","first-page":"37681","DOI":"10.1074\/jbc.M301406200","article-title":"Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling","volume":"278","author":"Suo","year":"2003","journal-title":"J Biol Chem."},{"key":"B292","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1074\/jbc.M507753200","article-title":"Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs","volume":"281","author":"Khlistunova","year":"2006","journal-title":"J Biol Chem."},{"key":"B293","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1073858404269955","article-title":"Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain","volume":"10","author":"Rohatgi","year":"2004","journal-title":"Neuroscientist"},{"key":"B294","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/01.jnen.0000196133.74087.cb","article-title":"Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain","volume":"65","author":"Arai","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"key":"B295","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.neurobiolaging.2003.07.007","article-title":"Thrombin, a mediator of neurotoxicity and memory impairment","volume":"25","author":"Mhatre","year":"2004","journal-title":"Neurobiol Aging"},{"key":"B296","doi-asserted-by":"publisher","first-page":"S537","DOI":"10.3233\/JAD-141557","article-title":"Targeting thrombin: an inflammatory neurotoxin in Alzheimer's disease","volume":"42","author":"Grammas","year":"2014","journal-title":"J Alzheimer's Dis"},{"key":"B297","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/01.jnen.0000195941.48033.eb","article-title":"Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase","volume":"65","author":"Ishida","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1089\/neu.2000.17.1191","article-title":"Upregulation of neurotoxic serine proteases, prothrombin, and protease-activated receptor 1 early after spinal cord injury","volume":"17","author":"Citron","year":"2000","journal-title":"J Neurotrau."},{"key":"B299","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1084\/jem.20071427","article-title":"Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo","volume":"205","author":"Chen","year":"2008","journal-title":"J Exp Med."},{"key":"B300","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.neuroscience.2008.10.030","article-title":"Wobbler mice modeling motor neuron disease display elevated transactive response DNA binding protein","volume":"158","author":"Dennis","year":"2009","journal-title":"Neuroscience"},{"key":"B301","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF02737122","article-title":"Quantitative reverse transcriptase PCR to gauge increased protease-activated receptor 1 (PAR-1) mRNA copy numbers in the Wobbler mutant mouse","volume":"10","author":"Salcedo","year":"1998","journal-title":"J Mol Neurosci"},{"key":"B302","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/BF03401784","article-title":"Motor neuron cell death in wobbler mutant mice follows overexpression of the G-protein-coupled, protease-activated receptor for thrombin","volume":"6","author":"Festoff","year":"2000","journal-title":"Mol Med"},{"key":"B303","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/BF00356159","article-title":"The mouse homolog to the ras-related yeast gene YPT1 maps on chromosome 11 close to the wobbler (wr) locus","volume":"3","author":"Wichmann","year":"1992","journal-title":"Mamm Genome"},{"key":"B304","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ng1661","article-title":"Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse","volume":"37","author":"Schmitt-John","year":"2005","journal-title":"Nat Genet."},{"key":"B305","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1097\/00001756-199410000-00005","article-title":"Early detection of mouse wobbler mutation: a model of pathological motoneurone death","volume":"5","author":"des Portes","year":"1994","journal-title":"Neuroreport"},{"key":"B306","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/geno.1996.0140","article-title":"YAC contigs of the Rab1 and wobbler (wr) spinal muscular atrophy gene region on proximal mouse chromosome 11 and of the homologous region on human chromosome 2p","volume":"32","author":"Wedemeyer","year":"1996","journal-title":"Genomics"},{"key":"B307","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-2007-999018","article-title":"Thrombin, its receptor and protease nexin I, its potent serpin, in the nervous system","volume":"22","author":"Festoff","year":"1996","journal-title":"Semi Thrombosis Hemostasis"},{"key":"B308","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1055\/s-0033-1357482","article-title":"Coagulation in inflammatory diseases of the central nervous system","volume":"39","author":"Chapman","year":"2013","journal-title":"Semi Thrombosis Hemostasis"},{"key":"B309","doi-asserted-by":"publisher","first-page":"E2128","DOI":"10.3390\/ijms18102128","article-title":"Neuro-coagulopathy: blood coagulation factors in central nervous system diseases","volume":"18","author":"De Luca","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B310","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrn.2018.13","article-title":"Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics","volume":"19","author":"Petersen","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"B311","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1046\/j.1471-4159.2002.00850.x","article-title":"Injury-induced \u201cswitch\u201d from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord","volume":"81","author":"Festoff","year":"2002","journal-title":"J Neurochem"},{"key":"B312","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jnc.12441","article-title":"Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1","volume":"128","author":"Oono","year":"2014","journal-title":"J Neurochem"},{"key":"B313","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3909\/ricm0754","article-title":"A Novel Inhibitor of Protease-activated Receptor 1: a review of chemical structure and mode of action","volume":"16","author":"Hashemzadeh","year":"2015","journal-title":"Cardiovasc Med."},{"key":"B314","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1097\/MJT.0000000000000395","article-title":"Vorapaxar and amyotrophic lateral sclerosis: coincidence or adverse association?","volume":"24","author":"Serebruany","year":"2017","journal-title":"Am J Ther."},{"key":"B315","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1182\/blood-2014-09-599910","article-title":"Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar","volume":"125","author":"Aisiku","year":"2015","journal-title":"Blood"},{"key":"B316","doi-asserted-by":"publisher","first-page":"E982","DOI":"10.1073\/pnas.1718600115","article-title":"PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury","volume":"115","author":"De Ceunynck","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B317","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.tips.2017.05.001","article-title":"Targeting PAR1: now what?","volume":"38","author":"Flaumenhaft","year":"2017","journal-title":"Trends Pharmacol Sci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T11:27:06Z","timestamp":1662895626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":317,"alternative-id":["10.3389\/fneur.2019.00059"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00059","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"article-number":"59"}}